GE HEALTHCARE, LANTHEUS BEGIN A PHASE 3 CLINICAL TRIAL OF FLURPIRIDAZ TO TREAT CAD
GE Healthcare and Lantheus Holdings Inc., parent company of Lantheus Medical Imaging Inc., have started a second Phase 3 clinical trial of Flurpiridaz 18F (called the AURORA study), an investigational agent being evaluated for the detection of coronary artery disease (CAD), the most common form of heart disease.1 CAD affects an estimated
STRADIS HEALTHCARE FACILITY EARNS ISO; 2 EXECS HIRED; WEBSITE REDESIGNED
Stradis Healthcare, a provider of custom procedure trays and minor kits, has had several big events this summer, including earning ISO 13485:2016 certification for its Waukegan, Ill., facility; hiring two new executives; and overhauling its website, stradishealthcare.com. . Stradis serves more than 1,500 surgical centers, private practices and purchasing
VIEWRAY CLEANS HOUSE IN SEARCH OF GROWTH, SHAREHOLDER VALUE
ViewRay Inc., the Oakwood Village-based maker of an MRI-guided radiation therapy system called MRIdian, has named medical device industry veterans Scott Drake as president and CEO, and Shar Matin as COO, effective immediately. Both men had been executives at Spectranetics Corp., a developer and manufacturer of minimally invasive cardiovascular devices,
ECHONOUS VEIN DESIGNED TO IMPROVE FIRST-TIME STICKS
EchoNous, a Seattle provider focused on delivering intelligent medical tools, has received U.S. Food and Drug Administration (FDA) 510(k) clearance for the EchoNous Vein, an ultrasound-based tool designed specifically for nurses to improve peripheral IV (PIV) catheter placements. Developed for usage across a wide range of patients including both adults
TELEFLEX TO ACQUIRE QT VASCULAR ASSETS, TAKES OPTION ON CHOCOLATE HEART DCB
QT Vascular has agreed to sell its non-drug coated coronary products to Teleflex, including its Chocolate XD and Glider, with an option to purchase its Chocolate Heart drug-coated coronary balloon catheter which is currently under development. Singapore-based QT Vascular has not released any financial details of the agreement, but said that it
STUDY SHOWS RESULTS CHANGING WHITE FAT INTO BROWN FAT FOR EASIER WEIGHT LOSS
Obesity results from excess white fat storage, making it difficult to treat because the effectiveness of diet, exercise, and systemic anti-obesity agents is limited, and in the latter case may cause serious side effects. As a result, researchers are investigating innovative strategies for localized delivery of fat burning compounds via
AVINGER RECEIVES FDA CLEARANCE FOR PANTHERIS DEVICE; SHARES AHEAD 47% PREMARKET
Avinger has received 510(k) clearance from the FDA for its next generation Pantheris Lumivascular atherectomy system, the first-ever image-guided atherectomy device for the treatment of peripheral artery disease (P.A.D.). Lumivascular is the only technology that combines real-time intravascular imaging with highly effective catheters for the treatment of P.A.D. The Company intends to launch two versions
MED-AESTHETIC SOLUTIONS INC., DEVELOPER OF SALT FACIAL, PARTNERS WITH AESTHETIC MANAGEMENT PARTNERS
Med-Aesthetic Solutions Inc., the developer and manufacturer of the proprietary SaltFacial skin renewal system, has formed a partnership with Aesthetic Management Partners to represent its product line exclusively, in select markets worldwide. The partnership commenced with a strong presence at The Aesthetic Show in Las Vegas in July. Aesthetic Management
DERMAKA HAS NEW ENHANCED NATURAL HEALING FORMULA
Dermaka cream is an all-natural plant-based product that aids in skin healing, rejuvenation, and substantially reduces redness and bruising. Dermaka cream was developed by Ronald Bush, MD, FACS, to minimize bruising and inflammatory responses of the skin in the post-operative period. While the product has been around for several
THE MARKETING BOT: HOW TO USE YOUR TIRELESS, HIGH-ROI MARKETING GENIUS
By Scott Harvey It’s been said, and it’s pretty well-accepted, that e-mail is the “killer app” that turned the Internet from an interesting technology into the behemoth it has become. There’s no question that email, and its offspring such as various messaging apps such as Facebook Messenger and WhatsApp, have